Results 11 to 20 of about 14,147 (241)
Platelet-Rich Plasma for Pleurodesis: An Experimental Study in Rabbits
Medicina, 2022 Background and Objectives: This study was designed to evaluate platelet-rich plasma (PRP) as a method of pleurodesis in a rabbit model. Pleurodesis with PRP was compared against the gold-standard use of talc.
Styliani Maria Kolokotroni +6 more
doaj +4 more sources
Clinical outcomes of chemical pleurodesis using a minocycline
Therapeutic Advances in Respiratory Disease, 2019 Background: Pleurodesis is often used to prevent the re-accumulation of a malignant pleural effusion (MPE). Intrapleural urokinase (IPUK) therapy facilitates lung re-expansion for patients with loculated MPE or a trapped lung that allows subsequent ...
Li-Han Hsu +6 more
doaj +2 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2018 Background Malignant pleural effusion (MPE) arises in advanced stages of malignancies and frequently carries a poor prognosis. The most common management of the patients with refractory MPE is pleurodesis.
Mohammed M.N AboZaid +2 more
doaj +2 more sources
Survival in patients with malignant pleural effusion undergoing talc pleurodesis. [PDF]
Lung Cancer, 2019 OBJECTIVES Recent observations indicate a potential survival benefit in patients with malignant pleural effusion (MPE) who achieve successful pleurodesis in comparison to patients who experience effusion recurrence post pleurodesis.
Maged Hassan +10 more
semanticscholar +3 more sources
The impact of repeated thoracentesis on the outcome of chemical pleurodesis in malignant pleural effusion [PDF]
Egyptian Journal of Chest Disease and Tuberculosis, 2012 Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cytokine as tumor necrosis factor-α (TNF-α) which may subsequently enhance the release of plasminogen activator inhibitor-1 (PAI-1) and lead to fibrin ...
Adel Salah +3 more
doaj +2 more sources
Palliative Medicine in Practice, 2022 Pleurodesis is a definitive management strategy in malignant pleural effusion, its history is briefly described, and a narrative review is made about its indication, patient selection, response predictors and ...
Radhika Banka +2 more
core +3 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2013 Background and objective: Malignant pleural effusion (MPE) is a common problem in patients with malignancies. Chemical pleurodesis is the most commonly used palliative option.
Khaled H. Mohamed, Osama A. Hassan
doaj +2 more sources
Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions
Revista Portuguesa de Pneumologia (English Edition), 2017 Introduction: Malignant pleural effusions are an important burden of malignant disease. Slurry talc pleurodesis remains one of the most common and effective therapeutic options.
P.S. Santos +4 more
doaj +2 more sources
Study of poly-ɛ-caprolactone membranes for pleurodesis
Journal of the Formosan Medical Association, 2017 Pleurodesis with biomaterial membrane is an emerging treatment method for pneumothorax. However, the ideal one for the common disease is still under debate.
Ke-Cheng Chen +7 more
doaj +2 more sources
Journal of Clinical Medicine, 2020 Patients with malignant pleural effusion (MPE) who underwent successful pleurodesis survive longer than those for whom it fails. We hypothesize that the therapy-induced inflammatory responses inhibit the cancer progression, and thereby lead to a longer ...
Li-Han Hsu +5 more
semanticscholar +2 more sources